Dr. James Fleshman on Minimally Invasive Surgery for Colorectal Cancer

James W. Fleshman, Jr., MD
Published: Wednesday, Apr 08, 2015



James W. Fleshman Jr, MD, from the Department of Surgery and Internal Medicine at Baylor University Medical Center, discusses the surgical management of colorectal cancer.

Minimally invasive surgical approaches, just as laparoscopy and robotic, benefit the patient in their long-term treatment, says Fleshman.

Patients who undergo minimally invasive surgery can receive chemotherapy sooner and have less down time and immune suppression. They also experience less pain, require fewer narcotics, and have less of stress response to the operation, explains Fleshman.


James W. Fleshman Jr, MD, from the Department of Surgery and Internal Medicine at Baylor University Medical Center, discusses the surgical management of colorectal cancer.

Minimally invasive surgical approaches, just as laparoscopy and robotic, benefit the patient in their long-term treatment, says Fleshman.

Patients who undergo minimally invasive surgery can receive chemotherapy sooner and have less down time and immune suppression. They also experience less pain, require fewer narcotics, and have less of stress response to the operation, explains Fleshman.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x